Verbatim response from ChatGPT
I don’t have live web access right now, so I can’t check 2026-specific changes or new entrants. Below are reputable online telehealth programs and services that were prominent for GLP‑1 (semaglutide/tirzepatide) weight‑loss care through 2024 and are good starting points to check in 2026. I give reasons why people choose them and what to verify for 2026. If you want, tell me your state, insurance status, and budget and I’ll tailor a short comparison checklist.
Top online GLP‑1 programs/services to consider (check current 2026 details before signing up)
-
PlushCare — national telemedicine platform with board‑certified MDs, lab coordination and established telehealth workflows. Good if you want primary‑care style continuity plus prescriptions and lab monitoring.
-
Ro (Roman / Rory / Ro Health) — consumer‑focused digital health company with streamlined telehealth visits and medication delivery. Often easy sign‑up and good logistics for prescriptions and refills.
-
Hims & Hers — large direct‑to‑consumer telehealth company that expanded into metabolic/weight management; easy subscription plans and centralized medication shipping. Good if you prefer a low‑friction, subscription model.
-
SteadyMD — matches you with one dedicated physician for ongoing care (better for people wanting continuity of care and personalized long‑term management).
-
One Medical (now part of Amazon) — primary care membership that integrates virtual and in‑person care; good choice if you want stronger integration with labs and in‑clinic visits alongside telehealth.
-
Onduo (Verily/Sanofi partnership) — diabetes/metabolic care program with clinical teams and data‑driven monitoring; strong for people with diabetes or complex metabolic issues.
-
Calibrate (metabolic coaching program) — built around long‑term behavioral coaching and medical management of metabolic health; useful if you want structured coaching paired with medication support. (Check current program offerings and whether they’re prescribing GLP‑1s in 2026.)
What to verify for each provider in 2026
- Which medications they actually prescribe (Wegovy, Ozempic, Zepbound, Mounjaro, generic semaglutide, compounded forms) and whether they prescribe off‑label.
- Whether they do baseline labs and ongoing monitoring (A1c, lipids, LFTs, pregnancy test if relevant, etc.).
- How follow‑up works (frequency of visits, coaching, dietitian access).
- Costs: initial visit fees, monthly program fees, drug cost, shipping, and whether they assist with prior authorization or insurance billing.
- Prescriber model and licensing (are prescribers MDs/NPs in your state?).
- Policies on compounded drugs — prefer licensed pharmacies and beware of non‑FDA compounded products.
- Safety screening: pregnancy/breastfeeding, personal/family med history (pancreatitis, thyroid cancer risk), and plan for side‑effect management.
Safety & practical notes
- GLP‑1s have side effects (nausea, GI symptoms) and rare but serious risks — need good medical oversight and baseline labs.
- Avoid vendors that skip any medical history, don’t require labs, or ship from unverified pharmacies.
- If you have type 1 diabetes, history of pancreatitis, are pregnant/planning pregnancy, or have active gallbladder disease, talk to a clinician before starting.
If you want, I can:
- Narrow this list to 3 top picks for your state and budget (tell me state/insurance/budget).
- Give a short script of questions to ask each provider (cost, monitoring, drug brand, refills, discontinuation plan).
- Help compare two providers if you give their names or links.